Kims Hospitals Profile
Key Indicators
- Authorised Capital ₹ 38.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 23.49 Cr
as on 02-07-2024
- Company Age 10 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 3.87%
(FY 2023)
- Ebitda -33.33%
(FY 2023)
- Net Worth -2.78%
(FY 2023)
- Total Assets -2.69%
(FY 2023)
About Kims Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 38.00 Cr and a paid-up capital of Rs 23.49 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Kims Hospitals Private Limited India is Kriti Agarwal as COMPANY SECRETARY. Swarna Mohan and Bhaskara Bollineni serve as directors at the Company.
- CIN/LLPIN
U85110AP2014PTC095812
- Company No.
095812
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2014
- Date of AGM
28 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Rajahmundry, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kims Hospitals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kriti Agarwal | Company Secretary | 01-Jul-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Swarna Mohan  | Director | 10-Dec-2014 | Current |
| Bhaskara Bollineni | Director | 10-Dec-2014 | Current |
Financial Performance and Corporate Structure Insights of Kims Hospitals.
Kims Hospitals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.87% increase in profit. The company's net worth dipped by a decrease of 2.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kims Hospitals?
In 2023, Kims Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Spanv Medisearch Lifesciences Private LimitedActive 6 years 11 monthsBhaskara Bollineni is a mutual person
- Iconkrishi Institute Of Medical Sciences Private LimitedActive 6 years 8 months
Swarna Mohan is a mutual person
- Krishna Institute Of Medical Sciences LimitedActive 51 years 4 months
Bhaskara Bollineni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kims Hospitals?
Unlock and access historical data on people associated with Kims Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kims Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kims Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
